share_log

C4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dubin Glenn

C4 Therapeutics | 4: Statement of changes in beneficial ownership of securities

C4 Therapeutics | 4：持股变动声明
美股sec公告 ·  04/02 16:36
Moomoo AI 已提取核心信息
Glenn Dubin, associated with C4 Therapeutics, Inc. [CCCC], completed a direct acquisition of 1,358 shares of common stock on April 1, 2024. The transaction was executed at a price of $8.10 per share, resulting in a total investment of $10,999.80. Following this transaction, Dubin's direct holdings in the company increased to 22,075 shares. Additionally, Dubin has indirect holdings totaling 790,607 shares, which are held through DF Investment Partners LLC and the G&E Dubin Family Foundation.
Glenn Dubin, associated with C4 Therapeutics, Inc. [CCCC], completed a direct acquisition of 1,358 shares of common stock on April 1, 2024. The transaction was executed at a price of $8.10 per share, resulting in a total investment of $10,999.80. Following this transaction, Dubin's direct holdings in the company increased to 22,075 shares. Additionally, Dubin has indirect holdings totaling 790,607 shares, which are held through DF Investment Partners LLC and the G&E Dubin Family Foundation.
与C4 Therapeutics, Inc. [CCCC] 相关的格伦·杜宾于2024年4月1日完成了对1,358股普通股的直接收购。该交易以每股8.10美元的价格执行，总投资额为10,999.80美元。在这笔交易之后，杜宾在该公司的直接持股量增加到22,075股。此外，杜宾间接持有的股票总额为790,607股，这些股票通过DF Investment Partners LLC和G＆E Dubin家族基金会持有。
与C4 Therapeutics, Inc. [CCCC] 相关的格伦·杜宾于2024年4月1日完成了对1,358股普通股的直接收购。该交易以每股8.10美元的价格执行，总投资额为10,999.80美元。在这笔交易之后，杜宾在该公司的直接持股量增加到22,075股。此外，杜宾间接持有的股票总额为790,607股，这些股票通过DF Investment Partners LLC和G＆E Dubin家族基金会持有。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息